NO972217D0 - Nye aminosyrederivater med forbedret multi-medikamentmotstandsaktivitet - Google Patents

Nye aminosyrederivater med forbedret multi-medikamentmotstandsaktivitet

Info

Publication number
NO972217D0
NO972217D0 NO972217A NO972217A NO972217D0 NO 972217 D0 NO972217 D0 NO 972217D0 NO 972217 A NO972217 A NO 972217A NO 972217 A NO972217 A NO 972217A NO 972217 D0 NO972217 D0 NO 972217D0
Authority
NO
Norway
Prior art keywords
amino acid
acid derivatives
drug resistance
improved multi
novel amino
Prior art date
Application number
NO972217A
Other languages
English (en)
Other versions
NO323292B1 (no
NO972217L (no
Inventor
Robert E Zelle
Matthew W Harding
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/377,285 external-priority patent/US5543423A/en
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of NO972217D0 publication Critical patent/NO972217D0/no
Publication of NO972217L publication Critical patent/NO972217L/no
Publication of NO323292B1 publication Critical patent/NO323292B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
NO19972217A 1994-11-16 1997-05-14 Nye aminosyrederivater med forbedret multi-medikamentell resistensaktivitet, fremgangsmate for deres fremstilling, sammensetninger inneholdende dem og deres anvendelse. NO323292B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34083094A 1994-11-16 1994-11-16
US08/377,285 US5543423A (en) 1994-11-16 1995-01-23 Amino acid derivatives with improved multi-drug resistance activity
PCT/US1995/014841 WO1996015101A1 (en) 1994-11-16 1995-11-13 Novel amino acid derivatives with improved multi-drug resistance activity

Publications (3)

Publication Number Publication Date
NO972217D0 true NO972217D0 (no) 1997-05-14
NO972217L NO972217L (no) 1997-06-17
NO323292B1 NO323292B1 (no) 2007-03-05

Family

ID=26992255

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972217A NO323292B1 (no) 1994-11-16 1997-05-14 Nye aminosyrederivater med forbedret multi-medikamentell resistensaktivitet, fremgangsmate for deres fremstilling, sammensetninger inneholdende dem og deres anvendelse.

Country Status (25)

Country Link
EP (1) EP0797567B1 (no)
JP (1) JP3921239B2 (no)
AP (1) AP781A (no)
AT (1) ATE259349T1 (no)
AU (1) AU689991B2 (no)
BR (1) BR9509698A (no)
CA (1) CA2224198A1 (no)
CZ (1) CZ298586B6 (no)
DE (1) DE69532561T2 (no)
DK (1) DK0797567T3 (no)
ES (1) ES2216022T3 (no)
FI (1) FI972086A (no)
HK (1) HK1003636A1 (no)
HU (1) HU226136B1 (no)
IL (1) IL115685A (no)
MX (1) MX9703621A (no)
NO (1) NO323292B1 (no)
NZ (2) NZ296474A (no)
PL (1) PL182327B1 (no)
PT (1) PT797567E (no)
RO (1) RO121113B1 (no)
SI (1) SI0797567T1 (no)
SK (1) SK282069B6 (no)
TJ (1) TJ321B (no)
WO (1) WO1996015101A1 (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846981A (en) * 1993-05-28 1998-12-08 Gpi Nil Holdings Inc. Inhibitors of rotamase enzyme activity
US5798355A (en) * 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
US5696135A (en) * 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5801197A (en) * 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5786378A (en) * 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US6218424B1 (en) 1996-09-25 2001-04-17 Gpi Nil Holdings, Inc. Heterocyclic ketone and thioester compounds and uses
US5801187A (en) * 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US5840736A (en) 1996-11-13 1998-11-24 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5780484A (en) * 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US5811434A (en) * 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
US6242468B1 (en) * 1997-02-27 2001-06-05 Jia-He Li Carbamate and urea compositions and neurotrophic uses
US5846979A (en) 1997-02-28 1998-12-08 Gpi Nil Holdings, Inc. N-oxides of heterocyclic esters, amides, thioesters, and ketones
US6268384B1 (en) 1997-08-29 2001-07-31 Vertex Pharmaceuticals Incorporated Compounds possessing neuronal activity
WO1999062484A1 (en) * 1998-06-03 1999-12-09 Gpi Nil Holdings, Inc. Small molecule carbamate or urea hair growth compositions and uses
US6337340B1 (en) 1998-08-14 2002-01-08 Gpi Nil Holdings, Inc. Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
US6339101B1 (en) 1998-08-14 2002-01-15 Gpi Nil Holdings, Inc. N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders
US6335348B1 (en) 1998-08-14 2002-01-01 Gpi Nil Holdings, Inc. Nitrogen-containing linear and azepinyl/ compositions and uses for vision and memory disorders
US6376517B1 (en) 1998-08-14 2002-04-23 Gpi Nil Holdings, Inc. Pipecolic acid derivatives for vision and memory disorders
US6333340B1 (en) 1998-08-14 2001-12-25 Gpi Nil Holdings, Inc. Small molecule sulfonamides for vision and memory disorders
US6506788B1 (en) 1998-08-14 2003-01-14 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
US6399648B1 (en) 1998-08-14 2002-06-04 Gpi Nil Holdings, Inc. N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders
US6395758B1 (en) * 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US6384056B1 (en) 1998-08-14 2002-05-07 Gpi Nil Holdings, Inc. Heterocyclic thioesters or ketones for vision and memory disorders
US6218423B1 (en) 1998-08-14 2001-04-17 Gpi Nil Holdings, Inc. Pyrrolidine derivatives for vision and memory disorders
US7338976B1 (en) 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
JP2002525352A (ja) * 1998-09-30 2002-08-13 ザ、プロクター、エンド、ギャンブル、カンパニー ２−置換ケトアミド
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
AU2407400A (en) * 1999-01-08 2000-07-24 Vertex Pharmaceuticals Incorporated Process for the formation of intermediates useful for the preparation of pharmaceuticals
JP2001031635A (ja) * 1999-07-14 2001-02-06 Ajinomoto Co Inc 光学活性ｎ−保護−ｎ−メチル−フェニルアラニン誘導体の製造方法
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
CN1293042C (zh) * 2002-02-07 2007-01-03 远藤仁 芳香族氨基酸衍生物及其药物组合物
AU2010292148A1 (en) 2009-09-11 2012-04-12 Vertex Pharmaceuticals Incorporated Compositions of N-benzyl-3-(4-chlorophenyl)-2- [methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl) acetyl]amino]-N- [3-(4-pyridyl)-1-[2-[4-pyridyl)ethy]propyl]propanamide and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2074061A1 (en) * 1991-08-26 1993-02-27 Ivo Monkovic Benzamide multidrug resistance reversing agents
NZ314207A (en) * 1992-09-28 2000-12-22 Vertex Pharma 1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
US5744485A (en) * 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance

Also Published As

Publication number Publication date
PL320227A1 (en) 1997-09-15
SK61197A3 (en) 1997-11-05
AU689991B2 (en) 1998-04-09
PT797567E (pt) 2004-06-30
AP9700999A0 (en) 1997-07-31
DE69532561D1 (de) 2004-03-18
IL115685A0 (en) 1996-01-19
TJ321B (en) 2001-10-22
NZ333373A (en) 2000-07-28
AP781A (en) 1999-11-04
SK282069B6 (sk) 2001-10-08
FI972086A0 (fi) 1997-05-15
AU4109996A (en) 1996-06-06
CZ149197A3 (en) 1997-10-15
NO323292B1 (no) 2007-03-05
ATE259349T1 (de) 2004-02-15
RO121113B1 (ro) 2006-12-29
EP0797567B1 (en) 2004-02-11
JP3921239B2 (ja) 2007-05-30
FI972086A (fi) 1997-05-15
HU226136B1 (en) 2008-05-28
HUT77977A (hu) 1999-01-28
NZ296474A (en) 1999-01-28
WO1996015101A1 (en) 1996-05-23
BR9509698A (pt) 1998-06-30
PL182327B1 (pl) 2001-12-31
DK0797567T3 (da) 2004-06-14
CA2224198A1 (en) 1996-05-23
JPH10509151A (ja) 1998-09-08
NO972217L (no) 1997-06-17
IL115685A (en) 2000-08-31
MX9703621A (es) 1997-08-30
HK1003636A1 (en) 1998-11-06
CZ298586B6 (cs) 2007-11-14
EP0797567A1 (en) 1997-10-01
ES2216022T3 (es) 2004-10-16
DE69532561T2 (de) 2004-12-23
SI0797567T1 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
NO972217L (no) Nye aminosyrederivater med forbedret multi-medikamentmotstandsaktivitet
ZA959304B (en) Amino acid derivatives with improved multi-drug resistance activity
NO965394L (no) Nye substituerte purinylderivater med immunomodulerende aktivitet
DE59008394D1 (de) Aminosäureamid-Derivate.
PT900210E (pt) Derivados azahexano heterociclicos com actividade antviral
NO972525L (no) Nye benzimidazolderivater med antihistaminaktivitet
NO983356L (no) Nye 19-nor-pregnenderivater
NO970088L (no) Acylazolonderivater med anti-Helicobacteraktivitet
MC2103A1 (fr) Derives d'aminoacides
CZ174399A3 (cs) Derivát benzamidu substituovaný heterocyklickými skupinami a jeho použití
FI954255A0 (fi) 2,9-diamino- ja 2-amino-8-karbaomyyli-4-hydroksi-alkaanihappoamidijohdannaiset
NO901759L (no) Dipeptid-derivater med enzym-hemmende virkning.
NO970086D0 (no) Heterocykliske azolonderivater med anti-Helicobacteraktivitet
NO970684D0 (no) Nye N-substituerte naftokondenserte laktamer
NO960268D0 (no) Nye dialkoksypyridinylbenzimidazolderivater
DK71786D0 (da) 1,8-naphthyridinderivater med antibakteriel aktivitet
DE59006688D1 (de) Substituierte Aminosäureamid-Derivate, deren Herstellung und Verwendung.
DE69508700D1 (de) Aminosäurederivat mit Anti-CCK-Aktivität
DE59002430D1 (de) Cyclopropanoylaminosäureamid-Derivate.
NO993013D0 (no) Nye heterosykliske substituerte pyrrolidinamidderivater
NO983918L (no) Nye ureaderivater
FI960119A0 (fi) Peptidit, joilla on oksitosiinin vastaista aktiivisuutta
SE8903369D0 (sv) Motstaandssvetsning med mellanlaegg
ATE70053T1 (de) Heterocyclische amidderivate.
NO920307L (no) Nye dihydro-isokinolinderivater med farmasoeytisk virkning

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees